3-氨基-1-[5,6-二氢-3-(三氟甲基)-1,2,4-噻唑并[4,3-a]吡嗪-7(8H)-基]-4-(2,4,5-三氟苯基)-2-丁烯-1-酮
更新时间：2024-01-03 23:20:17
![3-氨基-1-[5,6-二氢-3-(三氟甲基)-1,2,4-噻唑并[4,3-a]吡嗪-7(8H)-基]-4-(2,4,5-三氟苯基)-2-丁烯-1-酮结构式](https://image.chemsrc.com/caspic/313/847445-81-2.png)
3-氨基-1-[5,6-二氢-3-(三氟甲基)-1,2,4-噻唑并[4,3-a]吡嗪-7(8H)-基]-4-(2,4,5-三氟苯基)-2-丁烯-1-酮结构式
|
常用名 | 3-氨基-1-[5,6-二氢-3-(三氟甲基)-1,2,4-噻唑并[4,3-a]吡嗪-7(8H)-基]-4-(2,4,5-三氟苯基)-2-丁烯-1-酮 | 英文名 | 3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUT-2-EN-1-ONE |
|---|---|---|---|---|
| CAS号 | 847445-81-2 | 分子量 | 405.298 | |
| 密度 | 1.6±0.1 g/cm3 | 沸点 | 555.1±60.0 °C at 760 mmHg | |
| 分子式 | C16H13F6N5O | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 289.5±32.9 °C |
| 中文名 | 3-氨基-1-[5,6-二氢-3-(三氟甲基)-1,2,4-噻唑并[4,3-a]吡嗪-7(8H)-基]-4-(2,4,5-三氟苯基)-2-丁烯-1-酮 |
|---|---|
| 英文名 | 3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one |
| 英文别名 | 更多 |
| 密度 | 1.6±0.1 g/cm3 |
|---|---|
| 沸点 | 555.1±60.0 °C at 760 mmHg |
| 分子式 | C16H13F6N5O |
| 分子量 | 405.298 |
| 闪点 | 289.5±32.9 °C |
| 精确质量 | 405.102417 |
| PSA | 77.04000 |
| LogP | 1.29 |
| 蒸汽压 | 0.0±1.5 mmHg at 25°C |
| 折射率 | 1.590 |
|
~74%
3-氨基-1-[5,6-二氢-... 847445-81-2 |
| 文献：DR. REDDY'S LABORATORIES LIMITED; DR. REDDY'S LABORATORIES, INC. Patent: WO2009/85990 A2, 2009 ; Location in patent: Page/Page column 28 ; |
|
~%
3-氨基-1-[5,6-二氢-... 847445-81-2 |
| 文献：GLENMARK GENERICS LIMITED Patent: WO2009/84024 A2, 2009 ; Location in patent: Page/Page column 23-24 ; |
|
~%
3-氨基-1-[5,6-二氢-... 847445-81-2 |
| 文献：CADILA HEALTHCARE LIMITED Patent: US2011/213149 A1, 2011 ; |
![(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氢-[1,2,4]三唑并[4,3-a]吡嗪-7-(8H)-基]-1-(2,4,5-三氟苯基)丁-2-酮结构式](https://image.chemsrc.com/caspic/261/764667-65-4.png)
CAS号823817-56-7![(R/S)-3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one结构式](https://image.chemsrc.com/caspic/030/1253056-01-7.png)
CAS号1253056-01-7
CAS号486460-32-6| 3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one |
| 7-(1-oxo-3-amino-4-(2,4,5-trifluorophenyl)but-2-enyl)-3-trifluoromethyl-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine |
| 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine |
| 2-Buten-1-one, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)- |
| (2Z)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one |
| (2E/Z)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine |
| 2-Buten-1-one, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (2Z)- |
| T56 AN CNN GN&TJ BXFFF GV1UYZ1R BF DF EF |
| 3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one |
